Prognosis of hepatocellular carcinoma in the French overseas territories and comparison with a tertiary center in mainland France Alolia Aboikoni; Manon Allaire; Dominique Louvel; Marthe Alogo A. Nwatsok; Paul Ngock Dime; Ala Ouni; Larissa Tangan; Magaly Zappa; Kinan Drak Alsibai; Maylis Douine; Mathieu Nacher; Lucie Catherine; Cecilia Busso; Nathalie Ganne; Moana Gelu-Simeon;

Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab Lorenz Kocheise; Jan Kempski; Yunhe Tang; Lorenz Balcar; Victoria Berger; Miriam Tomczak; Joao Gorgulho; Ramsha Masood; Franziska Giehren; Constantin Schmidt; Jan P. Sutter; Thorben W. Fruendt; Francesca Pagani; Sophie Wulf; Julian Kött; Saskia Domanig; Anastasios Giannou; Tanja Bedke; Jöran Lücke; Tao Zhang; Siwen Zhang; Andres Machicote; Ansgar W. Lohse; Marianna Alunni-Fabbroni; Jens Ricke; Najib Ben Khaled; Matthias Pinter; Bernhard Scheiner; Samuel Huber; Johann von Felden; Ignazio Piseddu; Kornelius Schulze;

Stemness markers in hepatocellular carcinoma of Eastern vs. Western population: Etiology matters? Caecilia HC Sukowati; Korri El-Khobar; Chyntia Olivia Maurine Jasirwan; Juferdy Kurniawan; Rino Alvani Gani;